Molecular Formula | C12H12IN |
Molar Mass | 297.13 |
Melting Point | 166-168 °C |
Water Solubility | 0.1 M HCl: soluble |
Appearance | Form solid color yellow |
Storage Condition | desiccated |
Use | MPP iodide is a toxic metabolite of the neurotoxin MPTP, which causes Parkinson's disease symptoms in animal models by selectively destroying dopaminergic neurons in the substantia nigra. MPP ioside is absorbed into dopaminergic neurons by dopamine transporters and exerts neurotoxic effects on mitochondria by affecting respiratory chain complex I. MPP iodide is also a high affinity substrate for serotonin transporters (SERT). |
Hazard Symbols | T - Toxic |
Risk Codes | R23/24/25 - Toxic by inhalation, in contact with skin and if swallowed. R36/37/38 - Irritating to eyes, respiratory system and skin. R25 - Toxic if swallowed |
Safety Description | S26 - In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. S36 - Wear suitable protective clothing. S45 - In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.) |
UN IDs | UN 2811 6.1/PG 2 |
WGK Germany | 3 |
RTECS | UU6580000 |
MPP (1-3 mM; 24 hours) remarkably decreases the viability of cells.
MPP also inhibits the activity of nicotinamide adenosine dinucleotide (NADH)-linked respiration in mitochondrial preparations and impairs aerobic glycolysis, leading to the present belief that the inhibition of NADH-linked cell respiration may constitute the final molecular mechanism of MPP neurotoxicity.
Cell Viability Assay
Cell Line: | SH-SY5Y cells |
Concentration: | 1, 2, 3 mM |
Incubation Time: | 24 hours |
Result: | SH-SY5Y cells were treated with MPP , mimicking the progress of dopaminergic neurons loss in PD; Reduced cell viability in both dose-dependent (1, 2, 3 mM for 24 h) and time dependent (1 mM) manner. |